The Journal of Pathology 2008 Jeremy Jass prize for Research Excellence in Pathology

Peter A Hall; Richard Poulsom; Philip J Coates; Ming-Qing Du; Pancras C W Hogendoom; Louise J Jones; Marc Ladanyi; Graeme I Murray; Gerald Niedobitek

doi:10.1002/path.2634

The Journal of Pathology 2008 Jeremy Jass prize for Research Excellence in Pathology

Peter A Hall, Richard Poulsom, Philip J Coates, Ming-Qing Du, Pancras C W Hogendoom, Louise J Jones, Marc Ladanyi, Graeme I Murray, Gerald Niedobitek

Applied Medicine

Research output: Contribution to journal › Editorial › peer-review

Abstract

The first Jass Prize for Research Excellence has been awarded to a group from Hannover in Germany. These authors discovered the epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer and characterized its biological and clinical relevance. This frequent epigenetic silencing was found to occur early in the development of breast cancer, and illustrates another mechanism by which tumour development is influenced by genes that operate without expression as proteins. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Original language	English
Pages (from-to)	393-395
Number of pages	3
Journal	The Journal of pathology
Volume	219
Issue number	4
Early online date	22 Oct 2009
DOIs	https://doi.org/10.1002/path.2634
Publication status	Published - Dec 2009

Keywords

Jass
research prize
microRNA
breast
cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/path.2634

Cite this

@article{39418b33a1da4a25b281aaefc8b9dee7,

title = "The Journal of Pathology 2008 Jeremy Jass prize for Research Excellence in Pathology",

abstract = "The first Jass Prize for Research Excellence has been awarded to a group from Hannover in Germany. These authors discovered the epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer and characterized its biological and clinical relevance. This frequent epigenetic silencing was found to occur early in the development of breast cancer, and illustrates another mechanism by which tumour development is influenced by genes that operate without expression as proteins. Copyright {\textcopyright} 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.",

keywords = "Jass , research prize, microRNA, breast, cancer",

author = "Hall, {Peter A} and Richard Poulsom and Coates, {Philip J} and Ming-Qing Du and Hogendoom, {Pancras C W} and Jones, {Louise J} and Marc Ladanyi and Murray, {Graeme I} and Gerald Niedobitek",

year = "2009",

month = dec,

doi = "10.1002/path.2634",

language = "English",

volume = "219",

pages = "393--395",

journal = "The Journal of pathology",

issn = "0022-3417",

publisher = "Wiley",

number = "4",

}

TY - JOUR

T1 - The Journal of Pathology 2008 Jeremy Jass prize for Research Excellence in Pathology

AU - Hall, Peter A

AU - Poulsom, Richard

AU - Coates, Philip J

AU - Du, Ming-Qing

AU - Hogendoom, Pancras C W

AU - Jones, Louise J

AU - Ladanyi, Marc

AU - Murray, Graeme I

AU - Niedobitek, Gerald

PY - 2009/12

Y1 - 2009/12

N2 - The first Jass Prize for Research Excellence has been awarded to a group from Hannover in Germany. These authors discovered the epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer and characterized its biological and clinical relevance. This frequent epigenetic silencing was found to occur early in the development of breast cancer, and illustrates another mechanism by which tumour development is influenced by genes that operate without expression as proteins. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

AB - The first Jass Prize for Research Excellence has been awarded to a group from Hannover in Germany. These authors discovered the epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer and characterized its biological and clinical relevance. This frequent epigenetic silencing was found to occur early in the development of breast cancer, and illustrates another mechanism by which tumour development is influenced by genes that operate without expression as proteins. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

KW - Jass

KW - research prize

KW - microRNA

KW - breast

KW - cancer

U2 - 10.1002/path.2634

DO - 10.1002/path.2634

M3 - Editorial

SN - 0022-3417

VL - 219

SP - 393

EP - 395

JO - The Journal of pathology

JF - The Journal of pathology

IS - 4

ER -

The Journal of Pathology 2008 Jeremy Jass prize for Research Excellence in Pathology

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this